Skip to main content
. 2015 Mar 18;10(3):e0120633. doi: 10.1371/journal.pone.0120633

Table 2. Hazard ratios for all-cause and cardiovascular mortality according to serum MCP-1levels.

Baseline serum MCP-1 level P trend
<33.3% 33.3 to <66.7% ≥66.7
No. of subjects 470 468 473
Person-years 1477 1586 1602
All-cause mortality
  No. of death 33 27 57
  Adjustment for age and gender 1.42 (0.86–2.37) 1.00 1.98 (1.25–3.14) 0.01
  Multivariable adjustment*
    Model 1* 1.46 (0.87–2.43) 1.00 2.01 (1.27–3.19) 0.01
    Model 2 1.61 (0.95–2.72) 1.00 2.12 (1.31–3.42) 0.009
    Model 3 1.51 (0.89–2.58) 1.00 2.11 (1.31–3.40) 0.01
Cardiovascular mortality
  No. of death 24 19 45
  Adjustment for age and gender 1.46 (0.80–2.66) 1.00 2.23 (1.30–3.81) 0.01
  Multivariable adjustment*
    Model 1* 1.52 (0.83–2.79) 1.00 2.27 (1.32–3.90) 0.01
    Model 2 1.56 (0.84–2.92) 1.00 2.23 (1.27–3.89) 0.02
    Model 3 1.50 (0.80–2.81) 1.00 2.21 (1.27–3.87) 0.02

*Model 1 was adjusted for age, gender, education, leisure-time physical activity, smoking, and alcohol drinking.

Model 2 was adjusted for model 1 covariates plus history of heart failure, body mass index, systolic blood pressure, fasting plasma glucose, low-density lipoprotein cholesterol, glomerular filtration rate, use of antihypertensive, anti-diabetic, cholesterol-lowering, and anti-platelet drugs.

Model 3 was adjusted for model 2 covariates plus C-reactive protein.

MCP-1, monocyte chemoattractant protein-1.